Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why GenMark Stock Soared Today

TheMotleyFool

0 0

Why GenMark Stock Soared TodayPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Shares of GenMark Diagnostics (NASDAQ: GNMK) surged 29.6% on Monday after the molecular testing company said it has agreed to a merger with Swiss pharmaceutical giant Roche Holding (OTC: RHHBY).

Roche will conduct a tender offer to acquire all of GenMark's outstanding stock for $24.05 per share, a roughly 43% premium to the price at which its shares were trading before rumors of the merger emerged back in February. The all-cash deal values GenMark at roughly $1.8 billion. It's expected to close in the second quarter.

GenMark and Roche agreed to a merger on Monday. Image source: Getty Images.

Source Fool.com

Like: 0

GNMK

Teilen